PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China
· Delayed Price · Currency is CNY 37.79
+0.90 (2.44%)
Mar 10, 2026, 3:04 PM CST
SHE:300725 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,804 | 6,681 | 7,841 | 16,073 | 28,391 | 20,042 | Upgrade
|
| Market Cap Growth | 14.62% | -14.80% | -51.22% | -43.39% | 41.66% | 102.57% | Upgrade
|
| Enterprise Value | 8,004 | 7,577 | 8,455 | 16,316 | 27,695 | 19,782 | Upgrade
|
| Last Close Price | 37.79 | 33.33 | 38.55 | 78.87 | 139.14 | 103.83 | Upgrade
|
| PE Ratio | 37.83 | 30.43 | 39.73 | 51.15 | 58.35 | 108.80 | Upgrade
|
| Forward PE | 49.72 | 26.11 | 27.44 | 37.00 | 65.42 | 74.64 | Upgrade
|
| PS Ratio | 4.45 | 3.96 | 4.55 | 10.08 | 23.63 | 19.61 | Upgrade
|
| PB Ratio | 1.23 | 2.24 | 2.77 | 6.05 | 10.81 | 10.58 | Upgrade
|
| P/TBV Ratio | 1.32 | 2.65 | 3.31 | 7.34 | 14.49 | 10.95 | Upgrade
|
| P/FCF Ratio | 15.86 | 36.17 | - | - | - | 102.08 | Upgrade
|
| P/OCF Ratio | 13.39 | 22.06 | 31.77 | 65.18 | 119.28 | 73.82 | Upgrade
|
| EV/Sales Ratio | 4.04 | 4.49 | 4.90 | 10.23 | 23.05 | 19.35 | Upgrade
|
| EV/EBITDA Ratio | 20.67 | 21.32 | 22.59 | 44.53 | 85.84 | 83.72 | Upgrade
|
| EV/EBIT Ratio | 32.64 | 33.43 | 32.53 | 58.23 | 102.79 | 93.40 | Upgrade
|
| EV/FCF Ratio | 14.42 | 41.03 | - | - | - | 100.76 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.47 | 0.62 | 0.59 | 0.14 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.27 | 3.95 | 4.65 | 4.27 | 1.17 | 0.51 | Upgrade
|
| Debt / FCF Ratio | 0.19 | 7.66 | - | - | - | 0.61 | Upgrade
|
| Net Debt / Equity Ratio | -0.11 | 0.01 | 0.05 | -0.02 | -0.28 | -0.66 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.08 | 0.11 | 0.40 | -0.12 | -2.24 | -5.32 | Upgrade
|
| Net Debt / FCF Ratio | -1.44 | 0.22 | -2.14 | 0.14 | 2.70 | -6.40 | Upgrade
|
| Asset Turnover | 0.31 | 0.34 | 0.35 | 0.38 | 0.41 | 0.59 | Upgrade
|
| Inventory Turnover | 1.78 | 1.41 | 1.45 | 1.56 | 1.67 | 2.15 | Upgrade
|
| Quick Ratio | 2.17 | 2.48 | 1.97 | 2.64 | 1.66 | 3.25 | Upgrade
|
| Current Ratio | 4.59 | 3.63 | 2.67 | 3.60 | 2.29 | 3.94 | Upgrade
|
| Return on Equity (ROE) | 4.00% | 7.54% | 7.19% | 12.33% | 22.28% | 13.98% | Upgrade
|
| Return on Assets (ROA) | 2.41% | 2.82% | 3.26% | 4.18% | 5.68% | 7.66% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.44% | 6.65% | 8.29% | 12.41% | 21.04% | 31.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.40% | 5.40% | 6.40% | 6.80% | 9.90% | 10.90% | Upgrade
|
| Earnings Yield | 2.28% | 3.29% | 2.52% | 1.96% | 1.71% | 0.92% | Upgrade
|
| FCF Yield | 6.30% | 2.77% | -0.88% | -1.94% | -0.94% | 0.98% | Upgrade
|
| Dividend Yield | 0.76% | 0.84% | 0.80% | 0.13% | 0.07% | 0.07% | Upgrade
|
| Payout Ratio | 35.17% | 35.52% | 21.13% | 10.71% | 4.60% | 11.76% | Upgrade
|
| Buyback Yield / Dilution | -0.31% | 0.90% | -0.62% | -0.37% | -6.09% | -0.79% | Upgrade
|
| Total Shareholder Return | 0.43% | 1.74% | 0.18% | -0.24% | -6.02% | -0.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.